METTL3 and acute myeloid leukemia: To assess the pro-chemoresistance activity of METTL3 in a clinically relevant setting, we established patient-derived xenografts (PDXs), in which leukemic blast cells from the bone marrow of six AML patients were intravenously transplanted into NSG mice.